Giuseppe Lippolis
Lund University
11 Papers
6 Citations
Giuseppe Lippolis is an academic researcher from Lund University. The author has contributed to research in topics: Cancer & Prostate cancer. The author has an hindex of 3, co-authored 6 publications.
Chat about Author
Papers
A high-density tissue microarray from patients with clinically localized prostate cancer reveals ERG and TATI exclusivity in tumor cells.
TL;DR: A morphological basis for ERG and TATI exclusivity in prostate cancer cells is provided and future therapies should be based on a combination of different targets in order to eradicate tumor cells with gene fusions and cells expressing other tumor-associated antigens.
Automatic registration of multi-modal microscopy images for integrative analysis of prostate tissue sections
TL;DR: The proposed method is both reliable and fast and therefore well suited for automatic segmentation and analysis of specific areas of interest, combining morphological information with protein expression data from three consecutive tissue sections.
Tractable and Reliable Registration of 2D Point Sets
Erik Ask,Olof Enqvist,Linus Svärm,Fredrik Kahl,Fredrik Kahl,Giuseppe Lippolis +5 more
- 06 Sep 2014
TL;DR: In this paper, the registration error is based on a robust loss function and the worst-case running times are bounded by a low-degree polynomial in the number of correspondences.
Gender and Liver Steatosis Discriminate Different Physiological Patterns in Obese Patients Undergoing Bariatric Surgery: Obesity Center Cohort
Rossella Donghia,Andrea Vitale,Giuseppe Lippolis,G. De Pergola,Sara De Nucci,Roberta Rinaldi,Marina Liso,Cristiano Giardiello +7 more
TL;DR: In this article , the authors explored a new cohort of patients with obesity and evaluated the gender differences and the steatosis status within the gender group, finding that the prevalence in women was higher (72.40%) than men (27.60%).
•Dissertation
Image analysis of prostate cancer tissue biomarkers
Giuseppe Lippolis
- 01 Jan 2015
TL;DR: The expression of ERG (as a surrogate marker of TMPRSS2:ERG gene fusion status) and TATI proteins in a large TMA of localized prostate cancer patients observed a mutually exclusive expression pattern, further supporting the idea of tailored treatment for genotypically different cancers.